A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

This bill, designated as S. 4066 in the 119th Congress and introduced on March 11, 2026, aims to declare that the approved application for the drug mifepristone under the Federal Food, Drug, and Cosmetic Act for ending intrauterine pregnancies is considered withdrawn. Additionally, it seeks to create a Federal tort claim for harm caused to women by chemical abortion drugs along with other related purposes.